Chadwick Jeremy G (CIK 1388406) reported 32 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-24). Recent activity: Buy KYMR (100 shares), Buy KYMR (200 shares), Sell KYMR (300 shares), Buy KYMR (4,466 shares), Buy KYMR (785 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-24 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Buy | 100 | $3,017 |
| 2026-04-24 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Buy | 200 | $8,700 |
| 2026-04-24 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 300 | $27,000 |
| 2026-04-16 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Buy | 4,466 | $134,739 |
| 2026-04-16 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Buy | 785 | $34,148 |
| 2026-04-16 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 5,251 | $472,598 |
| 2026-04-16 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Buy | 1,300 | $56,550 |
| 2026-04-16 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 1,300 | $117,000 |
| 2026-03-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 6,105 | $487,606 |
| 2026-03-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 22,756 | $1.7M |
| 2026-03-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 52,975 | $4.1M |
| 2026-03-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 8,214 | $643,978 |
| 2026-03-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Buy | 84,400 | $2.5M |
| 2026-03-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 1,200 | $96,060 |
| 2026-03-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Buy | 24,727 | $732,908 |
| 2026-03-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 24,727 | $2.0M |
| 2026-03-11 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Buy | 20,000 | $870,000 |
| 2026-03-11 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 1,765 | $144,959 |
| 2026-03-11 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 12,882 | $1.1M |
| 2026-03-11 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 11,111 | $930,213 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Buy | 12,575 | $0 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 549 | $48,175 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 383 | $33,896 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 1,107 | $99,254 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 394 | $33,096 |
Source: SEC Form 4 filings · as of 2026-04-24